Percutaneous coronary interventions without on-site cardiac surgery: A stretch for much-needed evidence

American Heart Journal

Volumn 145, Issue 2, 2003, Pages 214-216

  Ryan, Thomas J ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CLINICAL STUDY; CONFIDENCE INTERVAL; CORONARY STENT; DIAGNOSTIC PROCEDURE; EDITORIAL; ELECTIVE SURGERY; EMERGENCY TREATMENT; EVIDENCE BASED MEDICINE; FOLLOW UP; HEART SURGERY; HOSPITAL; HUMAN; MORTALITY; OBSERVATION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PRODUCTIVITY; REVASCULARIZATION; RISK FACTOR; SAFETY; ST SEGMENT ELEVATION; SURGICAL TECHNIQUE;

EID: 0037326170     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2003.62     Document Type: Editorial

References (23)

1. Ting HH, Garratt KN, Singh M, et al. Low-risk percutaneous coronary interventions without on-site cardiac surgery: two years' observational experience and follow-up. Am Heart J 2002;145:278-84.
2. Smith SC, Dove JT, Jacobs AK, et al. ACC-AHA guidelines for percutaneous coronary intervention: a report of the ACC/AHA task force on practice guidelines. J Am Coll Cardiol 2001;3:2215-38.
3. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein 2b/3a receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
4. EPILOG Investigators. Platelet glycoprotein 2b/3a receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
5. EPISTENT Investigators. Randomized placebo-controlled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein 2b/3a blockade. Lancet 1998;352:87-92.
6. PURSUIT Investigators. Inhibition of platelet glycoprotein 2b/3a with eptifibatide in patients with acute coronary syndrome. N Engl J Med 1998;339:436-43.
7. PRISM-PLUS Investigators. Inhibition of the platelet glycoprotein 2b/3a receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97.
8. ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation: a randomized, placebo-controlled trial. Lancet 2000;356:2037-44.
9. Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation 2000;102:2945-51.
10. Aversano T, Aversano LT, Passamani E, et al. Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA 2002;287:1943-51.
11. Ryan TJ, Faxon DP, Gunnar RM, et al. ACC/AHA guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures. J Am Coll Cardiol 1988;12:529-45.
12. Circulation 1988;78:486-502.
13. Kimmel SE, Berlin JA, Laskey WK, et al. The relationship between coronary angioplasty procedure volume and major complications. JAMA 1995;274:1137-42.
14. Hannan E, Racz M, Ryan TJ, et al. Coronary angioplasty volume-outcome relationships for hospital and operators in New York State: 1991-1994. JAMA 1997;279:892-8.
15. Jollis JG, Peterson ED, Nelson CL, et al. Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients. Circulation 1997;95:2485-91.
16. Halm EA, Lee C, Chassin MR. How is volume related to quality in health care? a systematic review of the medical literature. In: Interpreting the volume-outcome relationship in the context of health care quality. Washington, DC: National Academy of Science; 2000 p. 27-62.
17. Tierstein PS. Credentialing for coronary intervention: practice makes perfect. Circulation 1997;95:2467-70.
18. Kastrati A, Neuman FJ, Schomig A. Operator volume and outcome of patients undergoing coronary stent placement. J Am Coll Cardiol 1998;32:970-6.
19. Wharton TP, McNamara NS, Fedele FA, et al. Primary angioplasty for the treatment of acute myocardial infarction: experience at two community hospitals without cardiac surgery. J Am Coll Cardiol 1999;33:1257-65.
20. Vogel J. Angioplasty in the patient with an evolving myocardial infarction: with and without surgical backup. Clin Cardiol 1992;15:880-2.
21. Weaver WD, Litwin PE, Martin JS. Use of direct angioplasty for treatment of patients with acute myocardial infarction in hospitals with and without on-site cardiac surgery. Circulation 1993;88:2067-75.
22. Smythe DW, Richards AM, Elliot JM. Direct angioplasty for myocardial infarction: one year experience in a center with surgical backup 220 miles away. J Invasive Cardiol 1997;9:324-32.
23. Epstein AM. Volume and outcome: it is time to move ahead. N Engl J Med 2002;346:1161-4.